Neogen (NEOG) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
1 Oct, 2026Opening remarks and agenda
Meeting opened with a welcome and explanation of rules of conduct for shareholder participation.
Shareholders were informed about the opportunity to submit questions for the Q&A session.
Confirmation of quorum with 80% of eligible shares represented, allowing the meeting to proceed.
Notice of meeting and annual report, including audited financials, were distributed to shareholders.
Board and executive committee updates
Three directors, Aashima Gupta, Raphael Rodriguez, and Catherine Woteki, were nominated for election to serve until the 2029 annual meeting.
Shareholder proposals
Five proposals were presented: election of directors, advisory vote on executive compensation, ratification of auditors, approval of the Amended and Restated Omnibus Incentive Plan, and amendment to the Employee Stock Purchase Plan.
Latest events from Neogen
- FY31 targets pair innovation-led growth with 30% adjusted EBITDA margin and ~80% FCF conversion.NEOG
Investor Day 2026 - Core growth and margin gains lifted FY27 guidance as the Petrifilm transition advanced.NEOG
Q1 2027 - Correction increases ESPP share reserve to 6,000,000; Board recommends approval.NEOG
Proxy filing - Virtual annual meeting to vote on directors, compensation, auditor, and plan amendments.NEOG
Proxy filing - Improved growth, leadership changes, and enhanced ESG drive key proxy proposals for 2026.NEOG
Proxy filing - Q4 core growth accelerated, margins improved, and FY27 guidance signals continued momentum.NEOG
Q4 2026 - Integration progress and international growth position the business for margin expansion and recovery.NEOG
2024 Wells Fargo Healthcare Conference - Q2 FY26 delivered 2.9% core growth, margin expansion, and a raised FY26 outlook.NEOG
Q2 2026 - Q2 revenue hit $230M as integration advances, margin initiatives progress, and global growth accelerates.NEOG
Piper Sandler 36th Annual Healthcare Conference